Literature DB >> 3881249

Involvement of the cholinergic system in insulin and glucagon oversecretion of genetic preobesity.

F Rohner-Jeanrenaud, B Jeanrenaud.   

Abstract

The etiology of the abnormal secretion of hormones from the endocrine pancreas of genetically obese (fa/fa) rats is unknown. In this study, we tested the postulate that there is an early occurrence of increased efferent parasympathetic activity to the endocrine pancreas of these rodents. Unweaned female 17-day-old pups were anesthetized and tested by an iv bolus of arginine to stimulate insulin and glucagon output. At the time of the tests, pups were indistinguishable from each other. They were, therefore, kept to adulthood to allow for their separation into an obese (25% of total animals) and a lean (75%) group. Those animals that became obese were retrospectively referred to as preobese. Basal insulinemia and glucagonemia were identical in the two groups, as were the dynamics of arginine-induced hormone release. However, arginine-induced insulin as well as glucagon output were higher in preobese than in lean pups. These two abnormalities were abolished by acute atropine pretreatment. It is concluded that the substrate-induced insulin and glucagon oversecretion of preobese pups is an early defect that is mediated via the vagus nerve.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3881249     DOI: 10.1210/endo-116-2-830

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  14 in total

Review 1.  Pediatric endocrine disorders of energy balance.

Authors:  Robert H Lustig
Journal:  Rev Endocr Metab Disord       Date:  2005-12       Impact factor: 6.514

2.  The MOR-1 opioid receptor regulates glucose homeostasis by modulating insulin secretion.

Authors:  Ting Wen; Bonnie Peng; John E Pintar
Journal:  Mol Endocrinol       Date:  2009-02-12

Review 3.  An hypothesis on the aetiology of obesity: dysfunction of the central nervous system as a primary cause.

Authors:  B Jeanrenaud
Journal:  Diabetologia       Date:  1985-08       Impact factor: 10.122

Review 4.  The pathogenesis of NIDDM: the role of the pancreatic beta cell.

Authors:  W S Zawalich; G G Kelley
Journal:  Diabetologia       Date:  1995-08       Impact factor: 10.122

Review 5.  Insulin, corticosterone and the autonomic nervous system in animal obesities: a viewpoint.

Authors:  B Jeanrenaud
Journal:  Diabetologia       Date:  1995-08       Impact factor: 10.122

Review 6.  How neural mediation of anticipatory and compensatory insulin release helps us tolerate food.

Authors:  Karen L Teff
Journal:  Physiol Behav       Date:  2011-01-20

7.  Metabolic consequences of hyperinsulinaemia imposed on normal rats on glucose handling by white adipose tissue, muscles and liver.

Authors:  I Cusin; J Terrettaz; F Rohner-Jeanrenaud; B Jeanrenaud
Journal:  Biochem J       Date:  1990-04-01       Impact factor: 3.857

8.  Effects of cholinergic blockade by pirenzepine on insulin and glucose response to oral and intravenous glucose and to arginine load in obesity.

Authors:  M Maccario; S Grottoli; M Procopio; S E Oleandri; G M Boffano; P Savio; F Camanni; E Ghigo
Journal:  J Endocrinol Invest       Date:  1997-01       Impact factor: 4.256

9.  Induction and reversibility of an obesity syndrome by intracerebroventricular neuropeptide Y administration to normal rats.

Authors:  R Vettor; N Zarjevski; I Cusin; F Rohner-Jeanrenaud; B Jeanrenaud
Journal:  Diabetologia       Date:  1994-12       Impact factor: 10.122

10.  Abnormal regulation of pancreatic glucagon secretion in obese fa/fa rats.

Authors:  F Rohner-Jeanrenaud; B Jeanrenaud
Journal:  Diabetologia       Date:  1988-04       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.